NEWS
By Bloomberg News | August 5, 2008
WCI Communities Inc., the homebuilder whose chairman is billionaire corporate raider Carl Icahn, filed for Chapter 11 bankruptcy protection after failing to obtain new financing and losing 90 percent of its value in the past year. Chief Executive Officer Jerry Starkey will leave and Chief Operating Officer David Fry, 48, will take over as interim CEO, Bonita Springs, Fla.-based WCI said in a statement yesterday. WCI, which has proposed building a controversial 23-story tower in Columbia, is in talks to receive $100 million in debtor-in-possession financing from several lenders, the statement said.
NEWS
By Jessica Guynn and Joseph Menn | May 14, 2008
SAN FRANCISCO - Billionaire investor Carl C. Icahn is weighing whether to use the stake he has amassed in Yahoo Inc. to launch a proxy fight to unseat some of the Internet pioneer's board members after Microsoft Corp.'s failed bid for the company, two people familiar with the matter said yesterday. Icahn has purchased about 50 million Yahoo shares, roughly 4 percent of the company, since Microsoft pulled its $47.5 billion offer for Yahoo, according to the people, who spoke on condition of anonymity because the talks were confidential.
NEWS
By Detroit Free Press | July 17, 2007
WILMINGTON, Del. -- With billionaire financier Carl C. Icahn teaming up with Lear Corp.'s top executives to take the company private, it should have been a slam dunk. But in a demonstration of shareholder democracy that stretched over five months, other investors blocked the sale. The results of the vote, announced yesterday afternoon at a special shareholders meeting, leave some questions about the future of the company and its largest shareholder: Will the stock rise or fall? Will Icahn try again to take over the company?
NEWS
By Bloomberg News | May 5, 2007
NEW YORK -- Carl C. Icahn, the billionaire investor seeking a spot on Motorola Inc.'s board, has won the support of ClearBridge Advisors, gaining one of the phone maker's biggest shareholders as an ally. ClearBridge, which owns 54 million Motorola shares, plans to vote for Icahn at Monday's annual meeting, according to a statement by the firm yesterday. ClearBridge, owned by Legg Mason Inc. of Baltimore, is the largest shareholder to back Icahn so far. ClearBridge's support may help Icahn put more pressure on Motorola Chief Executive Officer Edward N. Zander, at the helm as the world's second-biggest phone maker posted its first sales decline in almost four years amid price cuts.
NEWS
By Jay Hancock | April 25, 2007
The game at MedImmune was over on Valentine's Day, we can now see, when Carl C. Icahn disclosed that he had bought stock in the Gaithersburg biotech company worth $89.8 million. He didn't threaten a proxy fight against MedImmune until March, he later told The Washington Post, but he hardly needed to. Mere news that Icahn has taken a stake in your company delivers as message as obvious as a severed horse's head: Place all or part of your company up for sale, or prepare for war. On Monday, MedImmune agreed to sell itself to AstraZeneca for twice its stock market value from a few months earlier.
NEWS
By Bloomberg News | April 17, 2007
Billionaire investor Carl C. Icahn dropped his plans to propose an opposing slate of directors for the board of Gaithersburg-based MedImmune Inc., noting the biotechnology company's decision to seek a buyer. Icahn, in an e-mail statement yesterday, said he urged MedImmune "several weeks ago" to put the company up for sale. He also said at the time that he intended to nominate directors at the 2007 annual meeting "whose intention it would be to accomplish this." In pulling back yesterday, Icahn said he reserved the right to pursue the proxy fight if MedImmune, Maryland's largest biotech company in sales and employment, fails to complete a sale.
NEWS
By Tricia Bishop | February 16, 2007
Billionaire investor Carl C. Icahn has bought 2.8 million shares of MedImmune Inc. stock, a 1.2 percent stake that's large enough to fuel speculation that Maryland's largest biotech company is headed for a shake-up. New York investment group Matrix Asset Advisors, which owns about 1.7 million shares of MedImmune, or about 0.7 percent of the company, has been pushing for the Gaithersburg-based company to be sold. In a letter sent to MedImmune's board of directors Tuesday - the third of its kind - Matrix President David A. Katz said he was concerned shareholders were suffering "because of management's inability to deliver on its guidance and proffered expectations."
NEWS
By BLOOMBERG NEWS | August 11, 2006
NEW YORK -- ImClone Systems Inc., a biotechnology company best known for the Martha Stewart trading scandal, abandoned its search for a buyer yesterday and offered investor Carl C. Icahn three board seats. Its shares dropped the most in more than nine months. Multiple bidders failed to meet ImClone's price in an auction that began in January, interim Chief Executive Officer Joseph L. Fischer said. In May, ImClone relaxed its "poison pill" provision to give Icahn the opportunity to increase his stake from the current 10 percent and added a director he supported.
NEWS
By David Greising | September 10, 2005
When hedge fund investor Eddie Lampert decided to take over operating control of Sears Holdings on Thursday, he decided to take charge himself rather than leave the job to professional managers. It was a decision fraught with risk: a financial investor with virtually no management experience taking control of one of the nation's largest retailers. This sort of coup by bankroll happens rarely in business, and for good reason: It doesn't work. Cable titan Ted Turner became so frustrated with the play of his Atlanta Braves that he donned a baseball uniform and managed from the dugout until Major League Baseball forced him to stop.
NEWS
By Sallie Hofmeister | August 16, 2005
Accusing Time Warner Inc. of moving too slowly to improve its sluggish share price, billionaire investor Carl C. Icahn yesterday urged the world's largest entertainment company to separate its cable business from its entertainment properties and repurchase $20 billion worth of its stock. But many investors questioned whether a sale or spinoff of the company's cable business would improve the entertainment giant's value. While they welcome a bigger stock buyback, analysts said, it's not the best time to sell or spin off cable systems that have been trading at historic lows because of concerns about the heated rivalry with phone and satellite competitors.